Chen, Han
Venkatesh, Madhavan S.
Gόmez Ortega, Javier
Mahesh, Siddharth V.
Nandi, Tarak N.
Madduri, Ravi K. https://orcid.org/0000-0003-2130-2887
Pelka, Karin https://orcid.org/0000-0003-2856-8602
Theodoris, Christina V. https://orcid.org/0000-0003-1658-1447
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP5OD036170)
Burroughs Wellcome Fund (1022136.01)
Biswas Foundation, Milken Institute
National Science Foundation (2034836)
U.S. Department of Energy (DE-AC02-06CH11357)
U.S. Department of Energy (DE-AC02-06CH11357)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA259511)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (Cancer Cell Map Initiative)
Parker Institute for Cancer Immunotherapy, funds from the CRISPR Cure for Cancer Initiative, the UCSF Program for Breakthrough Biomedical Research, Biswas Foundation, and Milken Institute
Article History
Received: 9 June 2025
Accepted: 24 February 2026
First Online: 27 March 2026
Competing interests
: K.P. is a consultant to Santa Ana Bio, Inc. The other authors declare no competing interests.